RACCAGNI, ANGELO ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 2.157
NA - Nord America 1.735
AS - Asia 1.376
SA - Sud America 222
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 28
OC - Oceania 7
Totale 5.695
Nazione #
US - Stati Uniti d'America 1.627
RU - Federazione Russa 1.174
SG - Singapore 470
CN - Cina 467
IT - Italia 340
BR - Brasile 184
RO - Romania 171
VN - Vietnam 129
DE - Germania 126
HK - Hong Kong 125
GB - Regno Unito 73
FR - Francia 69
FI - Finlandia 50
CA - Canada 49
PL - Polonia 35
IN - India 34
MX - Messico 27
SE - Svezia 27
BD - Bangladesh 26
ID - Indonesia 26
AT - Austria 19
IQ - Iraq 19
NL - Olanda 19
AR - Argentina 18
JP - Giappone 16
ZA - Sudafrica 14
ES - Italia 12
LT - Lituania 12
JM - Giamaica 9
TR - Turchia 9
MY - Malesia 8
AU - Australia 7
BE - Belgio 6
VE - Venezuela 6
CR - Costa Rica 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
GT - Guatemala 4
KZ - Kazakistan 4
MA - Marocco 4
NP - Nepal 4
PK - Pakistan 4
RS - Serbia 4
UA - Ucraina 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
HN - Honduras 3
IE - Irlanda 3
IR - Iran 3
JO - Giordania 3
NI - Nicaragua 3
PE - Perù 3
SA - Arabia Saudita 3
AL - Albania 2
CH - Svizzera 2
IL - Israele 2
KR - Corea 2
NG - Nigeria 2
NO - Norvegia 2
PT - Portogallo 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TC - Turks e Caicos 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
VI - Stati Uniti Isole Vergini 1
Totale 5.526
Città #
Singapore 271
Ashburn 246
Moscow 212
San Jose 209
Hong Kong 122
Dallas 95
Milan 93
New York 87
Beijing 86
Council Bluffs 76
Shanghai 73
Munich 65
Los Angeles 58
Phoenix 47
Hefei 46
Santa Clara 45
Lauterbourg 41
Ho Chi Minh City 38
Orem 30
Hanoi 29
São Paulo 29
Warsaw 25
Denver 24
Gatchina 23
Turku 22
Boardman 21
St Petersburg 21
London 20
Nuremberg 19
Brooklyn 18
Helsinki 18
Rome 17
Atlanta 16
Chennai 15
Guangzhou 15
Houston 15
Tokyo 15
Falkenstein 14
Montreal 14
Poplar 14
Toronto 14
Amsterdam 13
Frankfurt am Main 13
Yekaterinburg 13
Chicago 12
Mexico City 12
Miano 12
Perm 12
Seattle 11
Stockholm 11
Lappeenranta 10
Naples 10
Turin 10
Johannesburg 9
Vienna 9
Jakarta 8
Nizhniy Novgorod 8
Rio de Janeiro 8
San Francisco 8
Baghdad 7
Cesano Boscone 7
Da Nang 7
Manchester 7
Shenzhen 7
Tianjin 7
Boston 6
Busto Arsizio 6
Haiphong 6
North Bergen 6
Orlando 6
Philadelphia 6
Querétaro 6
Voronezh 6
Ankara 5
Boca 5
Brasília 5
Brussels 5
Buffalo 5
Dhaka 5
Jiaxing 5
Memphis 5
Paris 5
Queens 5
Wroclaw 5
Bari 4
Barnet 4
Belgrade 4
Bologna 4
Calgary 4
Florence 4
Honolulu 4
Istanbul 4
Monsummano Terme 4
Mumbai 4
New Delhi 4
Pisa 4
Pune 4
Rostov-on-Don 4
Secaucus 4
Tashkent 4
Totale 2.756
Nome #
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 258
Viral bloodstream detection in mpox patients: An observational multicentric study 242
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 211
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 148
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 146
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 145
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics 142
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 141
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 132
HIV viral load monitoring during monkeypox virus infection among people with HIV 132
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report 126
Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience 126
Viral Hepatitis and Human Papillomavirus Vaccination during HIV Pre-Exposure Prophylaxis: Factors Associated with Missed Vaccination 124
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV 120
Mpox in people with past infection or a complete vaccination course: a global case series 118
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination 118
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy 116
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 116
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids 115
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 113
Beyond stigma: Monkeypox infection in a 27-year-old woman 113
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 110
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 109
Isolated monkeypox proctitis among men who have sex with men 107
Persistent ocular mpox infection in an immunocompetent individual 107
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 105
HIV-NAAT use for early detection of HIV infection among high-risk men who have sex with men in Italy 102
Sexually Transmitted Enteric Infections in Men Who Have Sex With Men Living With HIV Over 8 Years of Follow-up 101
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis 101
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 98
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 96
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis 94
Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men 93
Viral hepatitis and human papillomavirus vaccination during pre-exposure prophylaxis: factors associated with missed vaccination 92
Early Diagnosis and Linkage to Care: an Experience over 14 years of Point of Care Rapid HIV Testing 90
Proctitis and prostatitis by Neisseria meningitidis among MSM: A case series 90
Role of multi-site sampling in the diagnosis of human Monkeypox 89
Two individuals with potential monkeypox virus reinfection 89
Real-life use of cidofovir for the treatment of severe monkeypox cases 84
Vaccines against Emerging Sexually Transmitted Infections: Current Preventive Tools and Future Perspectives 82
Mpox Virus: Control of In-Hospital Occupational Transmission Experience from a Tertiary Level Hospital in Milan, Italy 79
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization 78
Multidrug-resistant Mycoplasma genitalium urethritis: successful eradication with sequential therapy 73
Rapid improvement of severe Mpox lesions with oral tecovirimat 65
Surge of Mpox Cases in Lombardy Region, Italy, October 2023—January 2024 62
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response 55
Unilateral Blepharoconjunctivitis due to Monkeypox Virus Infection 50
HIV and Sexual Health Awareness Among University Students: Findings from a World AIDS Day Survey in Milan 50
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan 29
Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV 28
Implementation of HIV pre-exposure prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE cohort survey 27
Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis 27
Neisseria gonorrhoeae Antimicrobial Resistance: The Future of Antibiotic Therapy 27
Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features 27
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 26
Gaps in HIV Pre-exposure Prophylaxis Acceptance: Findings from an Outpatient HIV Testing Service in Italy 24
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccination 20
Detection of Mpox Virus in Seminal Fluids: Implications for Sexual Transmission 20
Mpox DNA clearance in semen over 6-month follow-up 17
Emerging sexually transmitted infections outbreak: Dermatophytosis among men who have sex with men in Milan, Italy 16
Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues 15
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs 15
Long-term successfull management of recurrent episodes of nontuberculous mycobacterial infection in an apparently healthy Chinese woman 12
Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey 12
Totale 5.695
Categoria #
all - tutte 22.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 1 0 7 0 0
2022/202357 5 2 1 0 1 1 30 11 0 2 3 1
2023/2024266 3 2 39 24 34 68 15 28 0 9 11 33
2024/20251.118 56 11 55 45 79 111 333 93 72 53 79 131
2025/20263.372 247 186 106 406 327 138 283 312 890 256 123 98
2026/2027874 118 182 177 397 0 0 0 0 0 0 0 0
Totale 5.695